In patients with NSTE ACS, fondaparinux was not inferior to enoxaparin in reducing the occurrence of death, MI or refractory ischemia at 9 days, and was superior to enoxaparin in reducing death ...

Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...